Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

International Immunology

Volumn 10, Issue 2, 1998, Pages 195-202

  Kasahara, Yoshihito ^a   Wada, Taizo ^a   Niida, Yo ^a   Yachie, Akihiro ^a   Seki, Hidetoshi ^a   Ishida, Yasushi ^b   Sakai, Tsuyoshi ^c   Koizumi, Fumitomo ^c   Koizumi, Shoichi ^a   Miyawaki, Toshio ^c   Taniguchi, Noboru ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Apoptosis; sFas; sFas ligand; T cell activation

Indexed keywords

FAS ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CASE REPORT; CHILD; FEMALE; FETUS; GENE MUTATION; GRANULOCYTE; HEPATOSPLENOMEGALY; HUMAN; HYPERGAMMAGLOBULINEMIA; INFANT; INTRON; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; PANCYTOPENIA; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; CHILD, PRESCHOOL; FAS LIGAND PROTEIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MEMBRANE GLYCOPROTEINS; MUTATION;

EID: 6844240196     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.2.195     Document Type: Article

References (41)

1. Yonehara, S., Ishii, A. and Yonehara, M. 1989. A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor to tumor necrosis factor. J. Exp. Med. 169:1747.
2. Trauth, B. C., Klas, C., Peter, A. M. L., Matzku, S., Møiler, P, Falk, W., Debatin, K. M. and Krammer, P. H. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
3. Nagata, S. and Golstein, P. 1995. The Fas death factor. Science 267:1449.
4. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Semeshima, M., Hase, A., Seto, Y. and Nagata S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
5. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li, W. M., Richards, S., Dhein, J. and Trauth, B. C. 1992. Purification and molecular cloning of the APO-1 cell surface antigen: a member of the tumor necrosis factor/nerve growth factor receptor superfamily. sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
6. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A. and Nagata, S. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
7. Alderson, M. R., Tough, T. W., Davis, S. T., Braddy, S., Falk, B., Schooley., K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F, and Lynch, D. H. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
8. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373:438.
9. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., El, K. M., Sherr, D. H., Stanger, B. Z. and Marshak, R. A. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
10. Daniel, P. T. and Krammer, P. H. 1994. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152:5624.
11. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S. and Taniguchi, N. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
12. Mapara, M. Y., Bargou, R., Zugck, C., Dohner, H., Ustaoglu, F., Jonker, R. R., Krammer, P. H. and Dorken, B. 1993. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23:702.
13. Schattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K., Friedman, S. M. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
14. Iwai, K., Miyawaki, T., Takizawa, T., Konno, A,. Ohta, K., Yachie, A., Seki, H. and Taniguchi, N. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201.
15. Um, H.-D., Orenstein, J. M. and Wahl, S. M. 1996. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J. Immunol. 156:3469.
16. Kasahara, Y., Iwai, K., Yachie, A,. Ohta, K., Konno, A., Seki, H., Miyawaki, T. and Taniguchi, N. 1997. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1) mediated apoptosis of neutrophils. Blood 89:1748.
17. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K. M., Krammer, P. H. and Moller, P. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415.
18. Adachi, M., Watanabe-Fukunaga, R. and Nagata, S. 1993. Aberrant transcription cased by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl Acad. Sci. USA 90:1756.
19. Nagata, S. and Suda, T. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
20. Takahashi, T., Tanaka, M., Brannan, C. L., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
21. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. and Puck, J. M. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
22. Rieux-Laucat, F., LeDeist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A. and de Villartay, J. P. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
23. Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J.-L. and Elkon, K.-B. 1996. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335:1643.
24. Le Deist, F., Emilie, J. F., Rieux-Laucat, F., Roberts, I., Brousse, N. and Fischer, A. 1996. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 348:719.
25. Sneller, M. C., Wang, J., Dale, J. K., Strober, W., Middelton, L. A., Choi, Y., Fleisher, T. A., Lim, M. S., Jaffe, E. S., Puck, J. M., Lenardo, M, J. and Straus, S. E. 1997. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341.
26. Bettinardi, A., Brugnoni, D., Quiroos-Roldan, E., Malagoli, A., La Grutta, S., Correra, A. and Notarangelo, L. D. 1997. Missense mutation in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 89:902.
27. Lynch, D. H., Ramsdell, F. and Alderson, M. R. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
28. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F. and Lynch, D. H. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
29. Aggarwal, B. B., Singh, S., La Pushin, R. and Totpal, K. 1995. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364:5.
30. Sato, T., Irie, S., Kitada, S. and Reed, J. C. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411.
31. Ohta, K., Iwai, K., Kasahara, Y., Taniguchi, N., Krajeski, S., Reed, J. C. and Miyawaki, T. 1995. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int. Immunol. 7:1817.
32. Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N. and Nagata, S. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl Acad. Sci. USA 93:2131.
33. Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N. and Nagata, S. 1996. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11:294.
34. Fraser, A. and Evan, G. 1996. A license to kill. Cell 85:781.
35. Cascino, I., Fiucci, G., Papoff, G. and Ruberti, G. 1995. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:2706.
36. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M.J., Kiefer, M. C., Barr, P. J. and Mountz, J. D. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759.
37. Knipping, E., Debatin, K. M., Stricker, K., Heilig, B., Eder, A. and Krammer, P. H. 1995. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemia. Blood 85:1562.
38. Diarzani, U., Bragardo, M., DiFranco, D., Alliaudi, C., Scagni, P., Buonfiglio, D., Redoglia, V., Bonissoni, S., Correra, A., Dianozani, I. and Ramenghi, L. 1997. Deficiency of Fas apoptotic pathway without Fas gene mutation in pediatric patients with autoimmunity/ lymphoproleferation. Blood 89:2871.
39. Fuss, I. J., Strober, W., Dale, J. K., Fritz, S., Pearlstein, G. R., Puck, J. M., Lenardo, M. J. and Straus, S. E. 1997. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J. Immunol 158:1912.
40. Behmann, I., Walczak, H. and Krammer, P. M. 1994. Structure of the human APO-1 gene. Eur. J. Immunol. 24:3057.
41. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H. and Nagata S. 1997. Fas ligand in human serum. Nat. Med. 2:317.